PAIGE WALLACE: Open Payments
NPI 1326686403 · FORT WORTH, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,205 in 57 payments from 12 companies in 2025. Trend: 2023 $163 · 2024 $1,140 · 2025 $1,205
Food & beverage: $1,121Education: $84
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 18 | $299 |
| Janssen Biotech, Inc. | 10 | $238 |
| Madrigal Pharmaceuticals | 5 | $161 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $143 |
| Ipsen Biopharmaceuticals, Inc | 5 | $103 |
| QOL Medical, LLC | 2 | $62 |
| Phathom Pharmaceuticals, Inc. | 6 | $59 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $46 |
| Ardelyx, Inc. | 1 | $26 |
| Phadia US Inc. | 1 | $25 |
Products named: TREMFYA, RINVOQ, REZDIFFRA, ENTYVIO, IQIRVO, Sucraid, VOQUEZNA, SKYRIZI.
Industry payments across TX — which companies pay providers there.
